Published in Boll Soc Ital Biol Sper on January 31, 1967
[Occupational neoplasms of the urinary tract]. Cancro (1973) 0.94
Cement, asbestos, and cement-asbestos pneumoconioses. Arch Environ Health (1975) 0.83
Immunological aspects of occupational lead exposure. Med Lav (1988) 0.81
[Work risks in the rubber industry and their prevention. I. Technological notes]. Arch Sci Med (Torino) (1968) 0.75
[Vestibular changes in toluene exposure]. Med Lav (1983) 0.75
[The osteocondensing variety of multiple myeloma. Review of the literature and description of a case]. Minerva Med (1983) 0.75
[Considerations on the subject of technical and biological prevention of saturnism]. Minerva Med (1966) 0.75
[Electrocardiographic findings in mixed pneumoconiosis caused by talc]. Med Lav (1963) 0.75
[Catabolism of amino ketones in hepatic insufficiency]. Boll Soc Ital Biol Sper (1964) 0.75
[Risk in welding operations. Etiopathogenetic, preventive and legislative considerations]. G Ital Med Lav (1983) 0.75
[Delta-aminolevulinic-dehydrase and delta-aminolevulinic-oxidase activity in subjects treated with nialamide]. Boll Soc Ital Biol Sper (1968) 0.75
[Aminoacetone in grave hepatic insufficiency]. Minerva Med (1967) 0.75
Immunological aspects of farmer's lung. A family study. Med Lav (1987) 0.75
[The aminoacetone in neoplastic tissues]. Boll Soc Ital Biol Sper (1966) 0.75
[Epidemiological study of silicosis among gneiss stone-cutters]. Med Lav (1967) 0.75
[Nasal patency patterns observed during working hours in a group of technicians habitually exposed to formaldehyde]. Acta Otorhinolaryngol Ital (1995) 0.75
[Industrial accidents and hotel- and home-related pathology]. G Ital Med Lav (1988) 0.75
[Rifampicin in therapy of pulmonary tuberculosis verified for the first time: clinico-causistic contribution]. G Ital Mal Torace (1969) 0.75
[Hemodynamic changes in acute experimental carbon monoxide poisoning. 2. Regional circulation (coronary, carotid, mesenteric renal, iliac)]. Med Lav (1969) 0.75
[Results of double-blind study with anticholinergic drugs]. Minerva Med (1973) 0.75
The prevention of stress ulcers in a burn unit. Acta Chir Plast (1982) 0.75
[Our experience in the treatment of the parkinsonian syndrome with L-dopa. I. Evaluation of the clinical results]. Riv Patol Nerv Ment (1969) 0.75
[Distribution of ALA-dehydrase and ALA-oxidase activity in rat organs]. Arch Sci Med (Torino) (1972) 0.75
[Oxidative deamination of aminoacetone in the rat liver]. Boll Soc Ital Biol Sper (1968) 0.75
[Experiences in the treatment of Parkinsonism with L-dopa. IV. Effects on the experimental extrapyranidal brady-akinesia in cats]. Riv Patol Nerv Ment (1970) 0.75
[Urinary excretion of aminoacetone in saturnism]. Boll Soc Ital Biol Sper (1964) 0.75
[Change of the pulmonary scintigraphic pattern caused by a new pyrazole derivative]. Minerva Med (1968) 0.75
[Case of acute promyelocytic leukemia]. Minerva Med (1970) 0.75
[Reclassification of multiple myeloma and calculation of the myelomatous mass as prognostic and therapeutic indications]. Recenti Prog Med (1982) 0.75
[A case-control study of multiple occupational risk factors in relation to laryngeal cancer]. Acta Otorhinolaryngol Ital (1992) 0.75
[Case of pulmonary silicosis of rapid development in a sandstone miner]. Folia Med (Napoli) (1968) 0.75
[Lung scintigraphy in asbestosis]. Med Lav (1967) 0.75
[Sphygmographic and rheographic findings in the aortic arch syndrome]. Minerva Cardioangiol (1968) 0.75
[In vitro effects of iproniazid on the ALA-dehydrase activity in the presence of metal ions]. Arch Sci Med (Torino) (1973) 0.75
[Removal of the inhibition of ALA-dehydrase caused by metals by iproniazid in rat liver homogenates]. Boll Soc Ital Biol Sper (1967) 0.75
[Delta-aminolevulinic-oxidative activity in neoplastic tissues of the digestive system]. Boll Soc Ital Biol Sper (1968) 0.75
[Porphyrin metabolism and heart diseases]. Arch Sci Med (Torino) (1968) 0.75
[Experiences in the treatment of Parkinsonism with L-dopa. 3. Laboratory findings in patients treated with L-dopa]. Riv Patol Nerv Ment (1970) 0.75
[Erythrocyte delta-aminolevulinic acid oxidative activity. 3. Activators and inhibitors]. Boll Soc Ital Biol Sper (1968) 0.75
[Immunoelectrophoretic findings on serum proteins of patients with liver cirrhosis in relation to its clinical course]. Minerva Gastroenterol (1970) 0.75
[Ferrochelatase, ALA-dehydrase and ALA-synthetase activities in normal human tissues]. Arch Sci Med (Torino) (1967) 0.75
[Evaluation of the local peripheral blood flow in senile arteriosclerotic or diabetic arteriopathies]. Minerva Cardioangiol (1968) 0.75
[Serum levels of folinic acid in some cases of acute leukemia and acute erythremia. Values in basal conditions and after administration of folic acid]. Boll Soc Ital Biol Sper (1967) 0.75
[Metabolism of aminoacetone and lead poisoning]. Med Lav (1967) 0.75
[Occupational risks and prevention in the rubber industry. II. Industrial and preventive hygiene]. Arch Sci Med (Torino) (1968) 0.75
Excretion kinetics of the rubber anti-oxidant N-isopropyl-N'-phenyl-p-phenylendiamine (IPPD). Int Arch Occup Environ Health (1987) 0.75
[Investigation of subjects exposed to mercury nitrate]. Arch Sci Med (Torino) (1981) 0.75
[Delta-aminolevulinic oxidase activity of human erythrocytes and plasma. I. Normal values]. Boll Soc Ital Biol Sper (1967) 0.75
Multiple myeloma associated with Kaposi sarcoma: a case report. Arch Geschwulstforsch (1983) 0.75
[Myeloma and bone tissue: several considerations]. Chir Organi Mov (1986) 0.75
[Some aspects of the erythrocyte enzyme picture in occupational carbon monoxide poisoning]. Med Lav (1963) 0.75
[Delta-aminolevulinic oxidase activity of rat liver homogenates in various experimental conditions]. Boll Soc Ital Biol Sper (1967) 0.75
[Our experience with the treatment of the parkinsonian syndrome with L-dopa. II. Instrumental evaluation of the kinetic changes]. Riv Patol Nerv Ment (1969) 0.75